New radiation approach targets lung cancer in patients with dangerous scarring

NCT ID NCT03485378

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times

Summary

This study tests a precise type of radiation (SABR) for people with early-stage non-small cell lung cancer who also have interstitial lung disease, a condition that causes lung scarring. The goal is to see if this treatment can control the cancer while keeping side effects manageable. About 39 participants will be grouped based on the severity of their lung disease and followed for survival and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Alberta Health Services, Cross Cancer Institude

    Edmonton, Alberta, T6G 1Z2, Canada

  • CHUM Université de Montréal

    Montreal, Quebec, H2X 0A9, Canada

  • Edinburgh Cancer Centre, Western General Hospital

    Edinburgh, EH4 2XU, United Kingdom

  • London Regional Cancer Program of the Lawson Health Research Institute

    London, Ontario, N6A 4L6, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5, Canada

  • UHN Princess Margaret Cancer Centre

    Toronto, Ontario, M5G 2M9, Canada

Conditions

Explore the condition pages connected to this study.